BBH

VanEck Biotech ETFVanEck

$187.69-4.35 (-2.26%)Close

AUM$379.5M

Expense Ratio0.35%

NAV$192.01

Holdings26

InceptionDec 20, 2011

Price Chart

Key Statistics

Previous Close

$192.04

Day Range

$187.69$189.77

52-Week Range

$140.05$200.03

Avg Volume

7.3K

Dividend Yield

0.50%

Expense Ratio

0.35%

AUM

$379.5M

Shares Outstanding

2.1M

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	88.19%
Netherlands	5.23%
Switzerland	3.10%
Germany	1.92%
Ireland	1.46%
Other	0.11%

Fund Information

Issuer: VanEck
Category: Healthcare
Subcategory: Biotech
Inception Date: Dec 20, 2011
Exchange: NASDAQ
Description: VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
IWM	iShares Russell 2000 ETF	$70.17B	0.19%	1,934
XLV	State Street Health Care Select Sector SPDR ETF	$40.61B	0.08%	60
VHT	Vanguard Health Care ETF	$19.80B	0.09%	411
COWZ	Pacer US Cash Cows 100 ETF	$18.40B	0.49%	103
VTWO	Vanguard Russell 2000 ETF	$14.50B	0.06%	1,969

The VanEck Biotech ETF (BBH) is an exchange-traded fund issued by VanEck that launched on Dec 20, 2011. It currently manages $379.5M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 26 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 72.9% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	GILD	Gilead Sciences Inc	17.09%	438,702	$65.2M
2	AMGN	Amgen Inc	17.00%	172,635	$64.8M
3	VRTX	Vertex Pharmaceuticals Inc	9.87%	75,360	$37.6M
4	REGN	Regeneron Pharmaceuticals Inc	7.59%	37,494	$28.9M
5	ARGX	Argenx Se	4.10%	21,023	$15.6M
6	NTRA	Natera Inc	3.65%	69,950	$13.9M
7	ALNY	Alnylam Pharmaceuticals Inc	3.52%	41,639	$13.4M
8	IQV	Iqvia Holdings Inc	3.39%	75,549	$12.9M
9	INSM	Insmed Inc	3.35%	88,709	$12.8M
10	BIIB	Biogen Inc	3.32%	67,189	$12.7M
11	UTHR	United Therapeutics Corp	3.21%	22,850	$12.2M
12	ONC	Beone Medicines Ltd	3.13%	39,064	$11.9M
13	MRNA	Moderna Inc	2.91%	201,651	$11.1M
14	ILMN	Illumina Inc	2.39%	74,425	$9.1M
15	EXAS	Exact Sciences Corp	2.20%	81,267	$8.4M

Detailed Returns

Period	ETF	Cat. Avg
1D	-2.26%	—
1W	-1.54%	—
1M	-1.16%	—
3M	+0.75%	—
6M	+16.09%	—
YTD	+1.27%	—
1Y	+19.23%	—
3Y	+23.18%	—
5Y	+7.97%	—

Moving Averages

20-Day MA

$194.86

Below 20-Day MA

50-Day MA

$194.31

Below 50-Day MA

200-Day MA

$173.22

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$200.03

Current Price

$187.69

52-Week Low

$140.05

$140.05$200.03

Current Yield

0.50%

Annual Dividend

$3.6697

Frequency

1x/year

Last Ex-Date

Dec 22, 2025

Dividend History

Ex-Date	Amount	Pay Date
Dec 22, 2025	$0.9565	Dec 26, 2025
Dec 23, 2024	$1.2517	Dec 24, 2024
Dec 18, 2023	$0.7127	Dec 22, 2023
Dec 19, 2022	$0.7488	Dec 23, 2022
Dec 20, 2021	$0.3972	Dec 27, 2021
Dec 21, 2020	$0.6079	Dec 28, 2020
Dec 23, 2019	$0.4724	Dec 30, 2019
Dec 20, 2018	$0.5510	Dec 27, 2018
Dec 18, 2017	$0.6830	Dec 22, 2017
Dec 19, 2016	$0.3270	Dec 23, 2016
Dec 21, 2015	$0.3370	Dec 28, 2015
Dec 23, 2013	$0.0030	Dec 30, 2013
Dec 24, 2012	$0.1660	Dec 31, 2012
Dec 24, 2012	$0.0180	Dec 31, 2012

Dividend Payments Over Time

Category Comparison

Metric	BBH	Healthcare(223 ETFs)	Biotech(39 ETFs)
Fund Info
Expense Ratio	0.35%	0.60%	0.84%
AUM	$379.5M	$1.25B	$1.62B
Dividend Yield	0.50%	2.75%	14.38%
Avg Volume	7.3K	769.9K	1.3M
Holdings	26	182	67
Performance
1-Month Return	-3.05%	-3.02%	-2.05%
6-Month Return	+13.82%	+5.85%	+15.05%
YTD Return	+1.47%	+0.17%	+1.05%
1-Year Return	+16.39%	+16.65%	+24.43%

Compare with Another ETF

Search for an ETF to compare with BBH: